Search

You searched for "interview"

553 results found

Benign prostatic hyperplasia: what are the benefits and harms of various surgical management options?

9 March 2020 | | URO - Functional / Reconstructive Urology, URO - Infection, URO - Neurourology, URO - Technology
Benign prostatic hyperplasia (BPH) is characterised by stromal and epithelial prostatic cell hyperplasia. The enlarged prostate may be associated with voiding and storage lower urinary tract symptoms (LUTS). These have been predominantly attributed to bladder outlet obstruction (BOO), assumed to...
European Urology journal cover image.

Male LUTS: where do we stand?

11 August 2021 | | URO - Functional / Reconstructive Urology, URO - Infection
Patients’ preferences and expectations depend on cultural, geographical, economic and national factors. Data from different countries should be interpreted with caution when applied to the individual patient. Patients rarely seek help for benign prostatic obstruction (BPO) unless urinary retention occurs,...

Tackling waiting lists with MediHire

8 November 2021 | Research & Development
Laser rental specialists MediHire enjoyed a busy two days at the recent BAUS Endourology exhibition, with surgeons interested...

Action Bladder Cancer UK offers grants for bladder cancer research

21 November 2024 | Charities, Awards, Conferences & Anniversaries, Research & Development
Action Bladder Cancer UK (ABC UK) is inviting applications for grants to support research into bladder cancer, encouraging projects that aim to improve bladder cancer care, treatment, or diagnosis.

Vasectomy Find: The UK’s #1 lead generation platform for urology services

20 October 2025 | Company Profiles
Vasectomy Find is transforming how urologists grow their private practices. As the UK’s only dedicated lead generation platform for urology, we connect patients actively searching for private urology services directly with trusted urologists like you. Each enquiry we share is...

Action Bladder Cancer UK to open applications for bladder cancer research grants

14 October 2025 | Charities, Research & Development
Action Bladder Cancer UK (ABC UK) will open applications in November 2024 for its 2026 research funding programmes, supporting projects that improve the care, treatment, or diagnosis of bladder cancer. Grants are offered under two schemes. The Improving Outcomes for...

Action Bladder Cancer UK offering grants for bladder cancer research

20 January 2026
Action Bladder Cancer UK (ABC UK) is inviting applications for its 2026 research funding programmes, supporting projects that improve the care, treatment or diagnosis of bladder cancer. Grants are offered under two schemes. The Improving Outcomes for Patients Programme (IOPP)...

ICS updates in continence care: the role of the nurse continence specialist in continence services

1 November 2016 | | URO - Functional / Reconstructive Urology
The nurse who specialises in continence care is recognised as a key member of interdisciplinary teams seeking to deliver high quality integrated continence services. The recently published international service specifications for continence care [1] supports the use of specialist continence...

Urodynamics in review: stress urinary incontinence in women produced by the Urodynamics Committee of the ICS

1 November 2018 | | URO - Functional / Reconstructive Urology, URO - Infection, URO - Neurourology
Urodynamic studies (UDS) are the best tools to objectively assess the lower urinary tract dysfunction (LUTD) of various aetiologies [1]. According to the general understanding and consensus of the medical community UDS should be performed only when they will change...

How can we be SMART with virtual consultations?

17 March 2021 | | URO - Technology
At the beginning of 2020, video conferencing and phone consultations accounted for less than 1% of all consultations. Now it is probably 70%. Whilst there are many remote consultation solutions available, Tina Marshall describes what the ideal solution should look...

Movember launches world’s largest cancer real world evidence network

6 December 2021 | URO - Urologic Oncology
Movember has launched the world’s largest prostate cancer and testicular clinical and research network, aimed at improving the overall survival and quality of life for those living with diseases that affect over 1.4 million men worldwide every year. The leading...

Management of stage 1 non-seminomatous germ cell tumours

1 November 2014 | | URO - Urologic Oncology
Testicular cancer (TC) is the most successfully treated solid tumour, achieving a cure rate of 90-95% [1-3]. Testicular cancer is relatively rare with an incidence of 2207 cases in the UK in 2014 [4] and yet is the most common...